Cambridge Trust Co. increased its stake in Silicon Laboratories, Inc. (NASDAQ:SLAB) by 8.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,482 shares of the semiconductor company’s stock after buying an additional 553 shares during the period. Cambridge Trust Co.’s holdings in Silicon Laboratories were worth $511,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the company. Wells Fargo & Company MN boosted its stake in Silicon Laboratories by 7.3% in the first quarter. Wells Fargo & Company MN now owns 80,849 shares of the semiconductor company’s stock valued at $5,947,000 after buying an additional 5,508 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in Silicon Laboratories by 1.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 14,656 shares of the semiconductor company’s stock valued at $1,078,000 after buying an additional 200 shares during the period. Old Mutual Global Investors UK Ltd. bought a new stake in Silicon Laboratories during the first quarter valued at approximately $656,000. Sawgrass Asset Management LLC bought a new stake in Silicon Laboratories during the first quarter valued at approximately $278,000. Finally, First Mercantile Trust Co. boosted its stake in Silicon Laboratories by 43.9% in the first quarter. First Mercantile Trust Co. now owns 10,091 shares of the semiconductor company’s stock valued at $743,000 after buying an additional 3,079 shares during the period. Institutional investors and hedge funds own 88.64% of the company’s stock.

Shares of Silicon Laboratories, Inc. (SLAB) opened at 75.05 on Monday. The firm has a market cap of $3.19 billion, a price-to-earnings ratio of 44.75 and a beta of 1.25. The company’s 50 day moving average price is $70.63 and its 200-day moving average price is $71.40. Silicon Laboratories, Inc. has a 1-year low of $52.00 and a 1-year high of $79.15.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Wednesday, July 26th. The semiconductor company reported $0.79 EPS for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.08. Silicon Laboratories had a return on equity of 11.15% and a net margin of 9.88%. The company had revenue of $190.10 million for the quarter, compared to the consensus estimate of $186.46 million. During the same quarter in the previous year, the business earned $0.75 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities analysts expect that Silicon Laboratories, Inc. will post $3.06 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/07/cambridge-trust-co-has-511000-stake-in-silicon-laboratories-inc-nasdaqslab.html.

Several research firms have recently commented on SLAB. Needham & Company LLC restated a “buy” rating and set a $85.00 price target (up previously from $80.00) on shares of Silicon Laboratories in a research note on Thursday, July 27th. Zacks Investment Research upgraded Silicon Laboratories from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research report on Thursday. Stifel Nicolaus reiterated a “buy” rating and issued a $85.00 price objective (up previously from $82.00) on shares of Silicon Laboratories in a research report on Thursday, July 27th. Canaccord Genuity reiterated a “buy” rating and issued a $83.00 price objective on shares of Silicon Laboratories in a research report on Thursday, April 27th. Finally, B. Riley reiterated a “buy” rating and issued a $81.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, April 26th. Two analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $80.70.

In other news, Director William P. Wood sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $76.35, for a total transaction of $381,750.00. Following the sale, the director now directly owns 30,526 shares of the company’s stock, valued at $2,330,660.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO George Tyson Tuttle sold 75,000 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $74.89, for a total value of $5,616,750.00. Following the sale, the chief executive officer now directly owns 208,592 shares in the company, valued at $15,621,454.88. The disclosure for this sale can be found here. Insiders sold a total of 98,500 shares of company stock worth $7,322,125 in the last three months. Company insiders own 34.82% of the company’s stock.

Silicon Laboratories Company Profile

Silicon Laboratories Inc is a provider of silicon, software and solutions for the Internet of Things (IoT), Internet infrastructure, industrial, consumer and automotive markets. The Company operates through mixed-signal analog intensive products segment. It provides analog-intensive, mixed-signal solutions for use in a range of electronic products in various applications for the IoT market.

Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories, Inc. (NASDAQ:SLAB).

Institutional Ownership by Quarter for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.